A joint effort of the American Society of Hematology (ASH) and the European Hematology Association (EHA), Translational Research Training in Hematology (TRTH) is a unique, year-long training and mentoring program focused on helping junior researchers build successful careers in hematologic translational research.

Each year, 20 early-career scientists (10 from North America and 10 from Europe) are selected to participate in the rigorous training program led by faculty who are international leaders in hematology. Topics covered include biostatistics and biomarkers, genetics and molecular biology, ethics, and phase I clinical study design.

Key Dates

Letter of Intent Deadline	June 21, 2018
Notification of Awards	Early December 2018
Spring Course in Italy	March 8-15, 2019

Corporate Support

ASH receives support for TRTH from: Astellas Pharma, Bristol-Myers Squibb, Gilead Sciences, Inc., and Takeda Oncology.

For information about supporting the award, visit ASH's Corporate Support page or contact development@hematology.org.

Questions?

For more information, please contact the EHA Executive Office at training@ehaweb.org.

back to top